{
    "clinical_study": {
        "@rank": "157900", 
        "arm_group": [
            {
                "arm_group_label": "Corneal Cross Linking", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will receive a standard corneal cross linking treatment"
            }, 
            {
                "arm_group_label": "Corneal Cross Linking and Topo Laser", 
                "arm_group_type": "Experimental", 
                "description": "Patients will receive a topography guided laser treatment in combination with a standard corneal cross linking treatment in the same session."
            }
        ], 
        "brief_summary": {
            "textblock": "Topography guided laser treatment enables the surgeon to correct higher order aberrations in\n      corneas with irregular astigmatism. Several case reports and small uncontrolled trials have\n      been published on the combination of this treatment with corneal cross linking (CCL) in\n      patients with ectatic corneal diseases.\n\n      This randomized study will evaluate the safety and efficacy of a combined treatment of\n      corneal cross linking with a partial topography guided excimer laser treatment in eyes with\n      progressive ectatic corneal diseases."
        }, 
        "brief_title": "Corneal Cross Linking and Topography Guided Excimer Laser Treatment", 
        "condition": [
            "Keratoconus", 
            "Pellucid Marginal Degeneration"
        ], 
        "condition_browse": {
            "mesh_term": "Keratoconus"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed informed consent\n\n          -  Patient age 18 - 40 years\n\n          -  Documented progressive corneal ectatic disease except post LASIK/LASEK ectasia\n\n        Exclusion Criteria:\n\n          -  Allergy to one of the used substances\n\n          -  Tendency towards excessive scar formation\n\n          -  Pregnancy\n\n          -  Rheumatic diseases\n\n          -  Central corneal thickness below 450 \u00b5m\n\n          -  Active infection of the study eye\n\n          -  Previous corneal surgery of the study eye"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 5, 2011", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01682993", 
            "org_study_id": "367/2009"
        }, 
        "intervention": [
            {
                "arm_group_label": "Corneal Cross Linking and Topo Laser", 
                "description": "A topography guided excimer laser treatment will be performed prior to CCL in one session.", 
                "intervention_name": "Topography guided Excimer Laser treatment and Corneal Cross Linking", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Corneal Cross Linking", 
                "description": "A standard corneal cross linking procedure will be performed in this arm.", 
                "intervention_name": "Corneal Cross Linking", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "corneal cross linking", 
            "topography guided excimer laser", 
            "Keratoconus", 
            "Pellucid marginal degeneration", 
            "Post Excimer ectasia"
        ], 
        "lastchanged_date": "December 4, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Vienna", 
                    "country": "Austria", 
                    "zip": "1090"
                }, 
                "name": "Medical University of Vienna, Department of Ophthalmology"
            }
        }, 
        "location_countries": {
            "country": "Austria"
        }, 
        "number_of_arms": "2", 
        "official_title": "Topography Guided Excimer Laser Surface Ablation in Combination With Corneal Cross-linking (CCL) in Patients With Progressive Ectatic Corneal Disorders.", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Austria: Ethikkommission", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Safety (Pachymetry, K-readings)", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "uncorrected visual acuity (UVCA)", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "best corrected visual acuity (BCVA)", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01682993"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical University of Vienna", 
            "investigator_full_name": "Gerald Schmidinger", 
            "investigator_title": "MD, Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Progression of ectatic disease (by use of maximum keratometry readings = Kmax)", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "source": "Medical University of Vienna", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medical University of Vienna", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}